Astrazeneca Submits Seroquel XR™ In Europe For The Treatment Of ... Medical News Today (press release), UK - ... up to 78 weeks of treatment; and a further short-term study involving 338 elderly patients. The short-term studies used the Montgomery-Åsberg Depression ... Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 ... |
Friday, June 13, 2008
Astrazeneca Submits Seroquel XR™ In Europe For The Treatment Of ... - Medical News Today (press release)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment